George E. Bigelow - Concepedia

Author

George E. Bigelow

Also Known As

G BIGELOW, G Bigelow, G E Bigelow, G. BIGELOW, G. Bigelow, G. E. BIGELOW, G. E. Bigelow, G.E. Bigelow, GEORGE BIGELOW, GEORGE E. BIGELOW

378

Publications

18.7K

Citations

H-Index

150

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Behavioral Pharma (United States)Johns Hopkins Bayview Medical Center Baltimore City Health Department

About

George E. Bigelow is an author at Johns Hopkins University specializing in addiction, substance abuse, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	52	121	6.7K
2	Arts	1	1	33
3	Business	1	1	88
4	Education	1	1	71
5	Engineering	1	1	367

George E. Bigelow

258

Publications

16.9K

Citations

H-Index

Page 1

	Year	Citations
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence Rolley E. Johnson, Mary Ann Chutuape, Eric C. Strain, New England Journal of Medicine	2000	628
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. Eric C. Strain, George E. Bigelow, Ira A. Liebson, PubMed	1999	445
An automated version of the digit symbol substitution test (DSST) Daniel R. McLeod, Roland R. Griffiths, George E. Bigelow, Behavior Research Methods Automated VersionEngineeringString-searching AlgorithmProgram AnalysisString Processing	1982	367
A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts Warren K. Bickel, Maxine L. Stitzer, George E. Bigelow, Clinical Pharmacology & Therapeutics	1988	263
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans Sharon Walsh, Eric C. Strain, M E Abreu, Psychopharmacology Molecular PharmacologySubstance AbuseHealth SciencesMedicineAddiction	2001	255
Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis Tory R. Spindle, Edward J. Cone, Nicolas J. Schlienz, JAMA Network Open	2018	248
Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans. Warren K. Bickel, Maxine L. Stitzer, George E. Bigelow, Journal of Pharmacology and Experimental Therapeutics	1988	225
A reinforcement-based Therapeutic Workplace for the treatment of drug abuse: Six-month abstinence outcomes. Kenneth Silverman, Dace S. Svikis, Elías Robles, Experimental and Clinical Psychopharmacology	2001	219
Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude Kenneth Silverman, Mary Ann Chutuape, George E. Bigelow, Psychopharmacology Substance AbuseBehavioral SciencesSubstance UseHealth SciencesPsychiatry	1999	214
Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end‐points in clinical trials Dennis M. Donovan, George E. Bigelow, Gregory S. Brigham, Addiction	2011	204

Page 1